Chest Computed Tomography (CT) Screening Study With Antibody Testing
NCT01203579 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-06-21
Summary
The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
David Midthun, MD · Mayo Clinic
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung
NCT05987189 ·Status: RECRUITING
-
Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer
NCT02519972 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332 ·Status: COMPLETED
-
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
NCT02059889 ·Status: WITHDRAWN ·Phase: NA
-
Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
NCT06577883 ·Status: RECRUITING
-
Early Detection of Lung Cancer In Patients With Chronic Chest Diseases
NCT06074978 ·Status: NOT_YET_RECRUITING
-
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
NCT02898441 ·Status: UNKNOWN ·Phase: NA
-
Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLC
NCT04372732 ·Status: UNKNOWN
-
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
NCT06849518 ·Status: RECRUITING ·Phase: NA
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
NCT00012103 ·Status: COMPLETED ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Validation of Low Dose CT for Diagnosis of Lung Nodules
NCT03681873 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
NCT01799135 ·Status: TERMINATED ·Phase: NA
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Early Detection of Lung Cancer
NCT03181256 ·Status: ACTIVE_NOT_RECRUITING
-
Early Lung Cancer Detection Using Computed Tomography
NCT00188734 ·Status: COMPLETED
-
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
NCT00733252 ·Status: WITHDRAWN
-
Image Discovering Early Lung Cancer Project
NCT01914458 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography
NCT02754388 ·Status: COMPLETED
-
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
NCT01039311 ·Status: TERMINATED
-
National Lung Screening Trial (NLST) Screening
NCT00047385 ·Status: COMPLETED ·Phase: PHASE3
-
Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer
NCT00006087 ·Status: UNKNOWN ·Phase: NA
-
PD-L1 Expression in Lung Cancer
NCT04992715 ·Status: UNKNOWN ·Phase: PHASE2